PolarityTE Inc.

PolarityTE — Investor Presentation (April 2018)

34 slides from PolarityTE's investor presentation, Apr 11, 2018

  1. Slide 1: PolarityTE: Where Self Regenerates Self

  2. Slide 2: Forward-looking statements and projections

    This presentation contains forward-looking statements and projections. The company makes no express or implied representation or warrant as to the completeness of this information or, in the case of projections, as to their attainability or the accuracy and completeness of the assumptions from which

  3. Slide 3: PolarityTE company description

    PolarityTE" A commercial-stage regenerative biomaterials and biotechnology company focused on transforming the lives of patients by delivering a range of functional tissues using our novel platform technology. oe

  4. Slide 4: Name one company or product that truly regenerates anything

    ZG Ask yourself—Name one company or product that Ao = truly regenerates ANYTHING? \“¥

  5. Slide 5: Slide 5

  6. Slide 6: SkinTE - Early-Stage Healing in Patients

    SkinTE™- Early-Stage Healing in Patients SkinTE™ was designed and developed to treat a full spectrum of defects and conditions of the skin in a manner which truly promotes and utilizes the concept of self regeneration early on in the healing process —Where Self Regenerates Self™ Conditions Treated w

  7. Slide 7: The Problem with Regenerative Medicine is Tissue Engineering

    The Problem with Regenerative Medicine—is Tissue Engineering RO a The Tissue Engineering Triad Tissue Engineered Skin Substitutes Tissue engineering triads, single cell suspension, growth factors, monolayer cultures and synthetic scaffolds struggle to regenerate complete functional tissues and are o

  8. Slide 8: Question: What Has Been Missing?

    Question: What Has Been Missi po-lar-iety: the asymmetric organization of cellular elements, which allows development of specialized tissue and downstream function. a PolarityTE

  9. Slide 9: Functional polarization of SkinTE

    The functional polarization of SkinTE is designed to regenerate full-thickness, hair-bearing skin with all of the appendages (hair follicle, glands, etc.) and layered interfaces (epidermis, dermis and hypodermis). We believe the subsequent full-thickness regeneration of SkinTE leads to improved thre

  10. Slide 10: PolarityTE - We Design Platform Technologies

    PolarityTE™ - We Design Platform Technologies We believe precise design and development of our Core TE Tissue Systems, utilizing novel Minimally Polarized Functional Units (MPFUs), permits us to regenerate a full spectrum of functionally-polarized complex tissues AUTOLOGOUS- FROM THE PATIENT FOR THE

  11. Slide 11: Our First Full-Thickness, Functionally-Polarized Tissue - SkinTE

    Our First Full-Thickness, Functionally-Polarized Tissue - SkinTE™ ( From a small piece of tissue to the regeneration, replacement and/or reconstruction of full-thickness, hair-bearing skin ] Product Designed for All SkinTE was specifically designed to reduce barriers to regenerative wound care treat

  12. Slide 12: SkinTE: Designed to Address Current Critical Unmet Needs

    SkinTE™: Designed to Address Current Critical Unmet Needs Different Cells and Structures Exist at Different Layers within the Skin—Taking Only Some of them Prevents the Regeneration of Full-Thickness Hair-Bearing Skin SKIN GRAFTS - LIMITED DONOR SKIN NATIVE DONOR SKIN IS LIMITED: Full-thickness auto

  13. Slide 13: SkinTE Compared to Commercially Available Skin

    nTE™ Compared to Commercially Available Skin SkinTE Skin is much more than a single layer to provide a barrier - it is the largest organ in the human body and requires regeneration of all components for normal function. “[W]ithout the component of the recipients own distinct epithelium and cellular

  14. Slide 14: The SkinTE Difference: Skin Regenerates Skin

    The SkinTE™ Difference Simply Put—Skin Regenerates Skin ‘SkinTE™ is Designed to Heal Like Native Full-thickness Hear-Bearing Skin, While Conventional Wound Care Stimulates Contraction and Scar Formation Direct Comparison of SkinTE Full-thickness Halr-bearing Skin Regeneration vs. Native Skin and Wou

  15. Slide 15: The SkinTE Difference - Directs Intelligent & Dynamic Healing

    The SkinTE™ Difference - Directs Intelligent & Dynamic Healing Mid-Stage Native Contracting Wound ‘argna Contraction and Migration —Epithel Migration Columns ‘SkinTE™ Mid-Stage Regenerative Wound Mi Stage Ain negative Convergence with Native Sin Native Healed and Contracted Wound Pseudo epitheium Co

  16. Slide 16: Full-Thickness Skin Regeneration in Full-Thickness Wounds

    Full-Thickness Skin Regeneration in Full-Thickness Wounds PolarityTE™ Minimally Polarized Function Units Regenerate the Appendages of the ‘Skin—Those Appendages then Regenerate the Full-Thickness Hait-Bearing Skin MPFU Regeneration of Appendages within the Skin Drives Directional Polarization of Cel

  17. Slide 17: Comparing the Clinical Standard of Care to SkinTE

    Comparing the Clinical Standard of Care to SkinTE™ Native Scar Healed Wound _Native Skin Skin defects heal through a process of wound contraction and often scar formation. While skin grafts reduce contraction, patients still have scars. SkinTE™ reduces scar formation and regenerates full- thickness,

  18. Slide 18: Native Skin

    Native Skin Ee Comparing SkinTE™ to Native Skin. Comparative of analysis of ancillary histology between SkinTE™ (left) and native skin (right). Ancillary stains include: Hematoxylin and Eosin, Trichrome and Periodic Acid-Schiff. The images and data presented here are from pre-clinical studies TT d

  19. Slide 19: SkinTE - Early-Stage Healing and Return of Pigment in Patients

    SkinTE™- Early-Stage Healing and Return of Pigment in Patients SkinTE™ was designed and developed to treat a full spectrum of defects and conditions of the skin in a manner which truly promotes and utilizes the concept of self regeneration early on in the healing process —Where Self Regenerates Self

  20. Slide 20: Technology Platform / Support Platform

    at hechnology Platform Support Platform 20.

  21. Slide 21: PolarityTE Real-Time Assistant App

    PolarityTE™ Real-Time Assistant App An advisor will be assigned to assist you. A New Way to Communicate and Use PolarityTE™ Products: The PolarityTE™ Real-Time Assistant App fori0S, Android and Computer Systems Allows Peer-to-Peer Support Between Medical Professionals and PolarityTE™ Physicians 24-h

  22. Slide 22: PolarityTE - Tackling the Regenerative Wound Care Market

    olarityTE™- Tackling the Regenerative Wound Care Market CURRENT MARKETS REMAIN UNDERPENETRATED Global markets for tissue engineering and regenerative medicine is expected to grow to > $100 billion by 2022, with a five-year CAGR of 26.0% Worldwide prevalence of wounds is exponentially rising in all c

  23. Slide 23: SkinTE Commercialization & Growth

    SkinTE™ Commercialization & Growth Allin One Systems for Easy Use A STRATEGIC MARKET RELEASE | Further Intellectual Property Development Staged market release goals for 2018 focus on building a robust foundation of clinical evidence in multiple wound types and practice settings Targeting recognized

  24. Slide 24: The Core PolarityTE Product Pipeline

    he Core PolarityTE Product Pipeline Tissue Product Ex Vivo Optimization Prototype Modeling Studies FDA Registration and Commercialization CT/P Registered & Commercially Avail Development Pipeline of PolarityTE Core “TE” Products. A pipeline chart depicting some of the public core “TE tissue product

  25. Slide 25: OsteoTE - Expected to Launch in Late 2018

    Os rsigoTEM- Expected to Launch in Late 2018 OsteoTE™ is an autologous - from the patient, forthe patient - productintended for bone repair, reconstruction, replacement, supplementation and regeneration, including in the long bone, craniomaxillofacial, spine, dental, hand and foot/ankle markets. oe

  26. Slide 26: Pre-Defect Native, Defect-Native (Gross), Defect Native (CT)

    Pre-Defect Native ( Defect-Native (Gross) Defect Native (CT) we lerc eet nat ~ thas ated (CT) Bis model system at timepoint T?",(b,) Gross image of surgically-created, complete, brparietal critical sized defects of both the left and right parietal bones within the in vivo model system at timepoint 1

  27. Slide 27: Polarized Interfaces Drive Vascularized Osteogenesis

    Polarized Interfaces Drive Vascularized Osteogenesis Comparing OsteoTE™ to Native Bone and Other Products ) OsteoTE, OsteoTE+BGMM® ___OsteoTE +DGM° Autologous Bone Plate. DBM + BMP2 ei a od 3 & 2 é 3 FA 8 3 + é sy & 8 & é g = 3 e = 3 6

  28. Slide 28: Integrative Angiogenesis and Osteogenesis

    Integrative Angiogenesis and Osteogenesis Correlate this with Functional Outcomes and Tissue Fingerprints ] Osteogenesis Profile c i P ? ‘ i i | Al ° a ' 4 E : ; it x if { | i Ai Pe a coe 4 : ‘SS ere i = : ' 5 1 i i | u IE. Sie. . a Angiogenesis Profile OsteoTE 486 OsteoTE+0G OsteotE Native Bone / |

  29. Slide 29: Johns Hopkins Plastic and Reconstructive Surgery team

    ‘Johns Hopkins Plastic a ‘Michael Neumelster, MD, FRCSC, FACS ie Mekal Ofcer Professor & Chairman of the Department of Surgery, The EhinG. Zook Endowed Chairin Plastic Surgery at Souther linois University Past President ofthe American Society of Reconstructive Micrasurgery, American : ‘Assocation fo

  30. Slide 30: Management and Board of Directors

    Management Denver Lough, MD, PhD Chairman & Chief Executive Officer Edward (Ned) Swanson, MD Chief Operating Officer, Director John Stetson Executive Vice President, Chief Financial Officer, Director The PolarityTEAM - Board of Directors | 7s >. Steve Gorlin Director Regenerative Medicine and Biotec

  31. Slide 31: The PolarityTEAM - Clinical Advisory Board

    ay The PolarityTEAM - Clinical Advisory Board

  32. Slide 32: Balance Sheet Highlights As of January 31, 2018

    Balance Sheet Highlights As of January 31, 20182 Cash and Cash Equivalents $9.99 Million Total Debt $0 Shares Issued and Outstanding’ As of March 14, 20182 Common Stock 16,457,664 ™ Warrants 0 Preferred Stock 0 Total Common Stock & Equivalents 16,457,664 lok wilvary wth tesonent needs 1. Alloutstand

  33. Slide 33: PolarityTE - Welcome to the SHIFT

    : PolarityTE™ - Welcome to the SHIFT™ Bf EVOLVING TECHNOLOGY PLATFORMS AND PRODUCTS ae re HP) We are a clinical stage, commercial biotechnology and regenerative materials company with new and expanding technology platforms which we believe can be utilized to create functionally-polarized tissues for

  34. Slide 34: Thank you. Questions?

Polarityte — Investor Presentation (April 2018) on 6ix